Company Profile

Arena is a biopharmaceutical company focused on discovering and developing novel, small molecule drugs. We are currently directing our activities and resources primarily on:


Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events & Presentations
Corporate Presentation
More information is coming soon.
Annual Report and Proxy Statement
Date Title and Summary
Toggle Summary Arena Pharmaceuticals Earns Prime Status from ISS ESG, a Leading Rating Agency for Sustainable Investments
- ISS ESG Corporate Rating uses comprehensive research and data to allow institutional investors to identify Environmental, Social and Governance (ESG) risks and seize investment opportunities - Inaugural year of Prime status for Arena, following the Company’s 2021 ESG Report launch PARK CITY, Utah
Toggle Summary Arena Reports First Quarter Financial Results with Strong Cash Position and Continued Progress on Pipeline Over the Quarter
– Liquidity position at $1.1 billion as of March 31, 2021 to support continued pipeline progress SAN DIEGO --(BUSINESS WIRE)--May 5, 2021-- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the first quarter ended March 31, 2021 .